Literature DB >> 28501796

Nitric oxide synthase inhibition restores orthostatic tolerance in young vasovagal syncope patients.

Julian M Stewart1,2, Richard Sutton3, Mira L Kothari1, Amanda M Goetz1, Paul Visintainer4, Marvin Scott Medow1,2.   

Abstract

OBJECTIVE: Syncope is sudden transient loss of consciousness and postural tone with spontaneous recovery; the most common form is vasovagal syncope (VVS). We previously demonstrated impaired post-synaptic adrenergic responsiveness in young VVS patients was reversed by blocking nitric oxide synthase (NOS). We hypothesised that nitric oxide may account for reduced orthostatic tolerance in young recurrent VVS patients.
METHODS: We recorded haemodynamics in supine VVS and healthy volunteers (aged 15-27 years), challenged with graded lower body negative pressure (LBNP) (-15, -30, -45 mm Hg each for 5 min, then -60 mm Hg for a maximum of 50 min) with and without NOS inhibitor NG-monomethyl-L-arginine acetate (L-NMMA). Saline plus phenylephrine (Saline+PE) was used as volume and pressor control for L-NMMA.
RESULTS: Controls endured 25.9±4.0 min of LBNP during Saline+PE compared with 11.6±1.4 min for fainters (p<0.001). After L-NMMA, control subjects endured 24.8±3.2 min compared with 22.6±1.6 min for fainters. Mean arterial pressure decreased more in VVS patients during LBNP with Saline+PE (p<0.001) which was reversed by L-NMMA; cardiac output decreased similarly in controls and VVS patients and was unaffected by L-NMMA. Total peripheral resistance increased for controls but decreased for VVS during Saline+PE (p<0.001) but was similar following L-NMMA. Splanchnic vascular resistance increased during LBNP in controls, but decreased in VVS patients following Saline+PE which L-NMMA restored.
CONCLUSIONS: We conclude that arterial vasoconstriction is impaired in young VVS patients, which is corrected by NOS inhibition. The data suggest that both pre- and post-synaptic arterial vasoconstriction may be affected by nitric oxide. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  neurologic events; pharmacology; vascular biology

Mesh:

Substances:

Year:  2017        PMID: 28501796      PMCID: PMC5819615          DOI: 10.1136/heartjnl-2017-311161

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  38 in total

1.  Transient orthostatic hypotension is common in adolescents.

Authors:  Julian M Stewart
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

2.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

3.  Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans.

Authors:  N M Dietz; J R Halliwill; J M Spielmann; L A Lawler; B G Papouchado; T J Eickhoff; M J Joyner
Journal:  J Appl Physiol (1985)       Date:  1997-06

4.  Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance.

Authors:  N D Vaziri; Y Ding; D S Sangha; R E Purdy
Journal:  J Appl Physiol (1985)       Date:  2000-07

5.  Effects of NO on baroreflex control of heart rate and renal nerve activity in conscious rabbits.

Authors:  J L Liu; H Murakami; I H Zucker
Journal:  Am J Physiol       Date:  1996-06

6.  Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents.

Authors:  Julian M Stewart; Kenneth J McLeod; Sanjukta Sanyal; Gilbert Herzberg; Leslie D Montgomery
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Inhibition of nitric oxide synthase does not alter dynamic cerebral autoregulation in humans.

Authors:  Rong Zhang; Thad E Wilson; Sarah Witkowski; Jian Cui; Graig G Crandall; Benjamin D Levine
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03       Impact factor: 4.733

8.  Combined head-up tilt and lower body suction: a test of orthostatic tolerance.

Authors:  K M el-Bedawi; R Hainsworth
Journal:  Clin Auton Res       Date:  1994-04       Impact factor: 4.435

9.  NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors.

Authors:  Xavier F Figueroa; Inés Poblete; Ricardo Fernández; Cristóbal Pedemonte; Víctor Cortés; J Pablo Huidobro-Toro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-05-08       Impact factor: 4.733

10.  Increased vasoconstriction predisposes to hyperpnea and postural faint.

Authors:  Indu Taneja; Marvin S Medow; June L Glover; Neeraj K Raghunath; Julian M Stewart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

View more
  7 in total

1.  The Benefits of Oral Rehydration on Orthostatic Intolerance in Children with Postural Tachycardia Syndrome.

Authors:  Marvin S Medow; Kenneth Guber; Shilpan Chokshi; Courtney Terilli; Paul Visintainer; Julian M Stewart
Journal:  J Pediatr       Date:  2019-08-09       Impact factor: 4.406

Review 2.  The pathophysiology of the vasovagal response.

Authors:  David L Jardine; Wouter Wieling; Michele Brignole; Jacques W M Lenders; Richard Sutton; Julian Stewart
Journal:  Heart Rhythm       Date:  2017-12-12       Impact factor: 6.343

Review 3.  Autonomic uprising: the tilt table test in autonomic medicine.

Authors:  William P Cheshire; David S Goldstein
Journal:  Clin Auton Res       Date:  2019-03-05       Impact factor: 4.435

4.  Mechanisms of tilt-induced vasovagal syncope in healthy volunteers and postural tachycardia syndrome patients without past history of syncope.

Authors:  Julian M Stewart; Mohamed A Shaban; Tyler Fialkoff; Brianna Tuma-Marcella; Paul Visintainer; Courtney Terilli; Marvin S Medow
Journal:  Physiol Rep       Date:  2019-08

5.  Vasoactive Biomarkers in Patients With Vasovagal Syncope During Head-Up Tilt Test: A Case-Control Study.

Authors:  Cláudia Madeira Miranda; Rose Mary Ferreira Lisboa da Silva; Vanessa Peruhybe-Magalhães; Josep Brugada
Journal:  Clin Med Insights Cardiol       Date:  2022-08-23

6.  Gut microbiota analysis and its significance in vasovagal syncope in children.

Authors:  Wei Bai; Selena Chen; Chao-Shu Tang; Jian-Guang Qi; Qing-Hua Cui; Ming Xu; Jun-Bao Du; Hong-Fang Jin
Journal:  Chin Med J (Engl)       Date:  2019-02       Impact factor: 2.628

7.  Serum Asymmetric Dimethylarginine Levels in Patients with Vasovagal Syncope.

Authors:  Adem Atıcı; Gonul Aciksari; Omer Faruk Baycan; Hasan Ali Barman; Mehmet Rasih Sonsöz; Mustafa Sahin; Ramazan Asoglu; Ahmet Demirkıran; Şeref Kul; Baris Gungor; Eser Durmaz; Ahmet Kaya Bilge; Irfan Sahin
Journal:  Medicina (Kaunas)       Date:  2019-10-29       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.